U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07007988) titled 'A Phase I Study of SIM0388 in Participants With Malignant Ascites.' on May 16.
Brief Summary: Malignant Ascites is a common complication of malignant tumor. The objective of this study is to evaluate the safety, efficacy, and pharmacokinetic characteristics of intraperitoneal perfusion with Docetaxel Polymeric Micelles (SIM0388) for injection in patients with malignant ascites
Study Start Date: April 24
Study Type: INTERVENTIONAL
Condition:
Malignant Ascites
Intervention:
DRUG: SIM0388
Abdominal perfusion
DRUG: SIM0388
Abdominal perfusion
Recruitment Status: RECRUITING
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Pub...